CoChat

AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer

Open access
Varga, Julia, Nicolas, Adele, Petrocelli, Valentina, Pesic, Marina, Mahmoud, Abdelrahman, Michels, Birgitta E., Etlioglu, Emre, Yepes, Diego, Häupl, Björn, Ziegler, Paul K., Bankov, Katrin, Wild, Peter J., Wanninger, Stefan, Medyouf, Hind, Farin, Henner F., Tejpar, Sabine, Oellerich, Thomas, Ruland, Jürgen, Siebel, Christian W., Greten, Florian R. · 2020 · Journal of Experimental Medicine
Cited by 93

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Recently, a transcriptome-based consensus molecular subtype (CMS) classification of colorectal cancer (CRC) has been established, which may ultimately help to individualize CRC therapy. However, the lack of animal models that faithfully recapitulate the different molecular subtypes impedes adequate preclinical testing of stratified therapeutic concepts. Here, we demonstrate that constitutive AKT activation in intestinal epithelial cells markedly enhances tumor invasion and metastasis in Trp53ΔIEC mice (Trp53ΔIECAktE17K) upon challenge with the carcinogen azoxymethane. Gene-expression profiling indicates that Trp53ΔIECAktE17K tumors resemble the human mesenchymal colorectal cancer subtype (CMS4), which is characterized by the poorest survival rate among the four CMSs. Trp53ΔIECAktE17K tumor cells are characterized by Notch3 up-regulation, and treatment of Trp53ΔIECAktE17K mice with a NOTCH3-inhibiting antibody reduces invasion and metastasis. In CRC patients, NOTCH3 expression correlates positively with tumor grading and the presence of lymph node as well as distant metastases and is specifically up-regulated in CMS4 tumors. Therefore, we suggest NOTCH3 as a putative target for advanced CMS4 CRC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20191515

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 93

Metadata

Authors
Varga, J., Nicolas, A., Petrocelli, V., Pesic, M., Mahmoud, A., Michels, B. E., Etlioglu, E., Yepes, D., Häupl, B., Ziegler, P. K., Bankov, K., Wild, P. J., Wanninger, S., Medyouf, H., Farin, H. F., Tejpar, S., Oellerich, T., Ruland, J., Siebel, C. W., & Greten, F. R.
Venue
Journal of Experimental Medicine
Published
2020-08-04
Volume
217
Issue
10
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W3047308150
Cited by
93
References
12
FWCI
4.57
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer. https://app.cochat.ai/papers/10.1084/jem.20191515
The paper
Varga, J., Nicolas, A., Petrocelli, V., Pesic, M., Mahmoud, A., Michels, B. E., Etlioglu, E., Yepes, D., Häupl, B., Ziegler, P. K., Bankov, K., Wild, P. J., Wanninger, S., Medyouf, H., Farin, H. F., Tejpar, S., Oellerich, T., Ruland, J., Siebel, C. W., & Greten, F. R. (2020). AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20191515

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.